Our Goal
Nanomics biotech is committed to creating world-class artificial intelligence digital proteomics platform to access human proteome and discover biomarkers in unprecedented ways leading the early detection of cancer and other diseases.
Mission
Bringing the benefits of proteomics to everyone.
Vision
Honesty and Integrity
Proactive and Self-Driven
Perceive and Act
Grow and Innovate
Energetic and Energize
Vision & Mission
Our Story
Following in the foosteps of genomics, proteomics wil usher in a new era of precision medicine in liquid biopsy, companion diagnostics, and early screening.
By assembling nanotech, automation, and artificial intelligence, our fully automated, high throughput platform will enable large-scale, rapid mining of the complete set of human plasma proteome and fundamentally transform the way we discover new biomarkers and drug targets.
Our 1,000-square-meter lab is equipped for reagent production and automated lab robotics, with a Class I medical device manufacturing license.
With 50 high-throughput multiplex proteomics platforms, the lab can handle over 100,000 samples annually.
Our Team.
Nanomics Biotech was founded by a nationally recognized innovation and entrepreneurship leader, with a core team hailing from the University of Chicago. More than 80% of the team focuses on technology and R&D.
